bpc-157 safety fda warning unapproved peptide approved status products fda warning unapproved peptide products bpc-157 bpc-157 fda warning ⚠️ Warning: In a series of votes,

Our experience shows that innovative research often involves combining compounds with distinct but complementary mechanisms

The majority of the studies (see above in red) are preclinical studies in rodents, the vast majority of which have been done by a single research group in Croatia, which has been rinsing and repeating the same approach for decades

Elevated serum B12 levels discovered incidentally on blood tests are often asymptomatic

Vitamin B12 injections provide targeted nutritional support, crucial for individuals with deficiencies or absorption issues

Severe vitamin B12 deficiency mimicking microangiopathic hemolytic anemia

Panel member Elizabeth Rebello, a pharmacist and anesthesiologist, told the committee that she voted no on BPC-157 because of the lack of efficacy data and safety concerns